• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依据世界卫生组织2016年指南,荧光原位杂交技术对1p、19q、9p和10q进行自动分析在少突胶质细胞瘤诊断和预后中的作用

Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.

作者信息

Michaud Karine, de Tayrac Marie, D'Astous Myreille, Duval Céline, Paquet Claudie, Samassekou Oumar, Gould Peter Vincent, Saikali Stéphan

机构信息

Department of Neurosurgery, Centre Hospitalier Universitaire de Québec, Québec, Canada.

Department of Genomic and Molecular Genetics, Centre Hospitalier Universitaire de Rennes, Rennes, France.

出版信息

PLoS One. 2016 Dec 28;11(12):e0168728. doi: 10.1371/journal.pone.0168728. eCollection 2016.

DOI:10.1371/journal.pone.0168728
PMID:28030632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5193469/
Abstract

OBJECTIVE

To study the feasibility and the diagnostic and prognostic interest of automated analysis of 1p, 19q, 9p and 10q status by FISH technique in oligodendroglial tumors.

METHODS

We analyzed a retrospective series of 33 consecutive gliomas with oligodendroglial histology (originally diagnosed as 24 oligodendrogliomas and 9 oligoastrocytomas). For all cases, automated FISH analysis of 1p, 19q, 9p and 10q status were performed and compared to clinical and histological data, ATRX, IDH1R132H and alpha-internexin status (studied by immunohistochemistry) and overall survival (OS). Manual analysis of 9p and 10q status were also performed and compared to automated analysis to verify the concordance of the two methods.

RESULTS

The 33 gliomas were reclassified into 13 low-grade oligodendrogliomas (OII), 10 anaplastic oligodendrogliomas (OIII), 3 diffuse astrocytomas (AII), 3 anaplastic astrocytomas (AIII) and 4 glioblastomas (GBM) according to the WHO 2016 histological criteria. The 1p and/or 19q imbalanced status were restricted to astrocytomas with no correlation to their grade or their OS. Chromosome 9p deletion was restricted to OIII (70%) and GBM (100%) and was correlated with a shorter OS in the total cohort (p = 0.0007), the oligodendroglioma cohort (p = 0.03) and the astrocytoma cohort (p = 0.001). Concordance between 9p manual and automated analysis was satisfactory (81%, κ = 0.69). Chromosome 10q deletion was restricted to GBMs (50%) and was correlated with a poor OS in both the total cohort (p = 0.003) and the astrocytoma (AS) cohort (p = 0.04). Concordance between manual and automated analysis was satisfactory (79%, κ = 0.62).

CONCLUSION

Automated analysis of 1p, 19q, 9p and 10q status by FISH is a reliable technique which allows for refined classification of oligodendroglial tumors. 1p and/or 19q imbalanced status is evidence of astrocytic differentiation. 9p deletion is found in high grade oligodendrogliomas and astrocytomas with a poor OS. 10q is related to GBM status and a poor OS.

摘要

目的

研究采用荧光原位杂交(FISH)技术自动分析少突胶质细胞瘤中1p、19q、9p和10q状态的可行性及其诊断和预后价值。

方法

我们回顾性分析了33例具有少突胶质细胞组织学特征的连续胶质瘤病例(最初诊断为24例少突胶质细胞瘤和9例少突星形细胞瘤)。对所有病例进行1p、19q、9p和10q状态的自动FISH分析,并与临床和组织学数据、ATRX、异柠檬酸脱氢酶1(IDH1)R132H突变状态及α-中间丝蛋白状态(通过免疫组织化学研究)和总生存期(OS)进行比较。同时也对9p和10q状态进行手工分析,并与自动分析结果进行比较,以验证两种方法的一致性。

结果

根据世界卫生组织2016年组织学标准,33例胶质瘤重新分类为13例低级别少突胶质细胞瘤(OII级)、10例间变性少突胶质细胞瘤(OIII级)、3例弥漫性星形细胞瘤(AII级)、3例间变性星形细胞瘤(AIII级)和4例胶质母细胞瘤(GBM)。1p和/或19q失衡状态仅限于星形细胞瘤,与肿瘤级别或总生存期无关。9号染色体短臂(9p)缺失仅限于OIII级(70%)和GBM(100%),在整个队列(p = 0.0007)、少突胶质细胞瘤队列(p = 0.03)和星形细胞瘤队列(p = 0.001)中与较短的总生存期相关。9p手工分析与自动分析之间的一致性良好(81%,κ = 0.69)。10号染色体长臂(10q)缺失仅限于GBM(50%),在整个队列(p = 0.003)和星形细胞瘤(AS)队列(p = 0.04)中均与较差的总生存期相关。手工分析与自动分析之间的一致性良好(79%,κ = 0.62)。

结论

通过FISH自动分析1p、19q、9p和10q状态是一种可靠的技术,可用于少突胶质细胞瘤的精确分类。1p和/或19q失衡状态是星形细胞分化的证据。9p缺失见于高级别少突胶质细胞瘤和星形细胞瘤,总生存期较差。10q与GBM状态及较差的总生存期相关。

相似文献

1
Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.依据世界卫生组织2016年指南,荧光原位杂交技术对1p、19q、9p和10q进行自动分析在少突胶质细胞瘤诊断和预后中的作用
PLoS One. 2016 Dec 28;11(12):e0168728. doi: 10.1371/journal.pone.0168728. eCollection 2016.
2
Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.利用放射治疗肿瘤学组试验的组织微阵列,通过荧光原位杂交分析1p、19q、9p和10q作为高级别星形细胞瘤的预后标志物。
Neuro Oncol. 2004 Apr;6(2):96-103. doi: 10.1215/s1152851703000231.
3
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.91例星形细胞瘤和少突胶质细胞瘤中1p、19q、10q、TP53、EGFR、CDK4和CDKN2A的组织学与分子遗传学分析的相关性
Clin Cancer Res. 2002 Jan;8(1):196-201.
4
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
5
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.在一项前瞻性随机研究中对间变性少突胶质细胞瘤进行的分子分析:来自 EORTC 研究 26951 的报告。
Neuro Oncol. 2009 Dec;11(6):737-46. doi: 10.1215/15228517-2009-011.
6
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.1p、19q、9p、10q及表皮生长因子受体荧光原位杂交分析在复发性少突胶质细胞瘤中的预后价值
J Neuropathol Exp Neurol. 2004 Apr;63(4):314-22. doi: 10.1093/jnen/63.4.314.
7
Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?1p、19q 和 10q 杂合性缺失可预测少突胶质细胞瘤的预后——走向个体化肿瘤治疗?
Neuro Oncol. 2010 May;12(5):490-9. doi: 10.1093/neuonc/nop071. Epub 2010 Feb 14.
8
Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.人类少突胶质细胞瘤中1号、10号和19号染色体异常的分子分析:杂合性缺失频率与分级、年龄及性别的关系
Clin Neuropathol. 2006 Jan-Feb;25(1):18-24.
9
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.染色体臂1p和19q的改变作为少突胶质细胞瘤、星形细胞瘤和混合性少突星形细胞瘤生存的预测指标。
J Clin Oncol. 2000 Feb;18(3):636-45. doi: 10.1200/JCO.2000.18.3.636.
10
1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma.1p/19q 共缺失纤维状星形细胞瘤:并非所有共缺失的都是少突胶质细胞瘤。
Ann Diagn Pathol. 2020 Jun;46:151519. doi: 10.1016/j.anndiagpath.2020.151519. Epub 2020 Apr 8.

引用本文的文献

1
1p and/or 19q polysomy is an adverse prognostic factor in oligodendrogliomas, and easy to detect by automated FISH.1p和/或19q多体性是少突胶质细胞瘤的不良预后因素,且易于通过自动化荧光原位杂交(FISH)检测到。
PLoS One. 2025 May 2;20(5):e0322809. doi: 10.1371/journal.pone.0322809. eCollection 2025.
2
Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrence.空间突触连接是少突胶质细胞瘤演变和复发的基础。
Res Sq. 2025 Apr 4:rs.3.rs-6299872. doi: 10.21203/rs.3.rs-6299872/v1.
3
Evaluation of ploidy and the DNA index by flow cytometry in central nervous system tumors: a review.

本文引用的文献

1
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类:概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
2
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.罕见低级别神经上皮肿瘤中的基因改变:BRAF、FGFR1和MYB突变高频发生且与形态学相符。
Acta Neuropathol. 2016 Jun;131(6):833-45. doi: 10.1007/s00401-016-1539-z. Epub 2016 Jan 25.
3
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas.
通过流式细胞术评估中枢神经系统肿瘤的倍性和 DNA 指数:综述。
Mol Biol Rep. 2024 Nov 11;51(1):1141. doi: 10.1007/s11033-024-10095-6.
4
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?IDH 突变型胶质瘤中肿瘤分级、年龄、强化和切除程度的生物学意义:在 IDH 抑制剂时代,它们应如何影响治疗决策?
Neuro Oncol. 2024 Oct 3;26(10):1805-1822. doi: 10.1093/neuonc/noae107.
5
Oligodendroglial tumours: subventricular zone involvement and seizure history are associated with CIC mutation status.少突胶质细胞瘤:室管膜下区受累和癫痫病史与 CIC 基因突变状态相关。
BMC Neurol. 2019 Jun 18;19(1):134. doi: 10.1186/s12883-019-1362-y.
6
A Comparative Review of Demographics, Incidence, and Epidemiology of Histologically Confirmed Intracranial Tumors in Brazil and Bulgaria.巴西和保加利亚经组织学确诊的颅内肿瘤的人口统计学、发病率及流行病学比较综述。
Cureus. 2018 Feb 19;10(2):e2203. doi: 10.7759/cureus.2203.
7
Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.9p 缺失及 p16、Cyclin D1 和 Myc 过表达对间变性少突胶质细胞瘤预后的影响。
PLoS One. 2018 Feb 28;13(2):e0193213. doi: 10.1371/journal.pone.0193213. eCollection 2018.
9p21.3的等位基因缺失是1p/19q共缺失间变性胶质瘤的一个预后因素。
Neurology. 2015 Oct 13;85(15):1325-31. doi: 10.1212/WNL.0000000000002014. Epub 2015 Sep 18.
4
Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm.荧光原位杂交技术对少突胶质细胞瘤1p/19q状态的自动化分析:原理及算法建议
PLoS One. 2015 Jul 2;10(7):e0132125. doi: 10.1371/journal.pone.0132125. eCollection 2015.
5
Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.单机构连续队列中具有星形细胞外观和1p19q完全缺失的胶质瘤的分子遗传学和临床特征
Oncotarget. 2015 Jun 30;6(18):15871-81. doi: 10.18632/oncotarget.3869.
6
Oligodendroglioma: pathology, molecular mechanisms and markers.少突胶质细胞瘤:病理学、分子机制及标志物
Acta Neuropathol. 2015 Jun;129(6):809-27. doi: 10.1007/s00401-015-1424-1. Epub 2015 May 6.
7
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.告别少突星形细胞瘤:原位分子遗传学支持将其归类为少突胶质细胞瘤或星形细胞瘤。
Acta Neuropathol. 2014 Oct;128(4):551-9. doi: 10.1007/s00401-014-1326-7. Epub 2014 Aug 21.
8
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.有丝分裂指数、微血管增殖和坏死将1p/19q共缺失的间变性少突胶质细胞瘤分为3组,这些组与不同的基因组改变相关。
Neuro Oncol. 2014 Sep;16(9):1244-54. doi: 10.1093/neuonc/nou047. Epub 2014 Apr 9.
9
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.1p/19q 共缺失的间变性少突胶质细胞瘤中的对比增强与 9p 缺失、基因组不稳定和血管生成基因表达相关。
Neuro Oncol. 2014 May;16(5):662-70. doi: 10.1093/neuonc/not235. Epub 2013 Dec 18.
10
Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.杂合性缺失 1p/19q 与脑胶质瘤患者生存:一项荟萃分析。
Neuro Oncol. 2014 Jan;16(1):103-12. doi: 10.1093/neuonc/not145. Epub 2013 Dec 4.